Mettis Global News
Mettis Global News
Mettis Global News
Mettis Global News

MPS Preview: SBP set to slash policy rate by 200bps

BF Biosciences starts production from new syringe line

BF Biosciences starts production from new syringe line
Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

November 14, 2024 (MLN): BF Biosciences Limited (PSX: BFBIO) has secured approval from Drug Regulatory of Pakistan (DRAP) for its brownfield expansion project along with commencement of commercial production from pre-filled syringes line.

BFBIO shared the development in its notice to the Pakistan Stock Exchange (PSX) on Thursday.

In continuation of the above, the company said the combi filling and lyophilization lines have been commissioned and commercial production has commenced.

Accordingly, the full Line II expansion project stands commissioned from today.

Furthermore, the company said it has already secured approvals for new products from DRAP and intends to launch these products in the coming months.

Copyright Mettis Link News

Posted on: 2024-11-14T15:21:21+05:00